IPCA Labs Fact Sheet, IPCA Labs Financial Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA Labs Fact Sheet    (IPLB)


Revealing at 5pm Today: The Great Indian Wealth Project


Here is the latest financial fact sheet of IPCA Labs. For more details, see the IPCA Labs quarterly results and IPCA Labs share price and chart. For a sector overview, read our pharmaceuticals sector report.

IPCA LABS Price History

Price Rs 2,178.1
Mkt Cap Rs m 274,874
Vol '000 1.1
P/E X 24.6
P/CF X 44.0
EPS (TTM) Rs 88.5
% ch % 1.4
No. of shares m 126.20
% ch week % 3.2
% ch 1-mth % 1.1
% ch 12-mth % 41.2
52 week H/L Rs 2,455.6/1,467.0
(As on May 17, 2021 09:52:00 AM)
* Results Consolidated
Excel EXPORT | DO YOU LIKE THESE FACTSHEETS? TELL US!

IPCA LABS Financials

No. of Mths
Year Ending
12
Mar-15
*
12
Mar-16
*
12
Mar-17
*
12
Mar-18
*
12
Mar-19
*
5-Yr Chart
Click to enlarge
IPCA LABS EQUITY SHARE DATA
High Rs8998886436951,042 
Low Rs591629503400590 
Sales per share (Unadj.) Rs249.2230.3254.5260.2298.6 
Earnings per share (Unadj.) Rs20.17.615.419.035.0 
Diluted earnings per shareRs20.17.615.419.035.0 
Cash flow per share (Unadj.) Rs34.420.629.133.149.4 
Dividends per share (Unadj.) Rs1.0001.001.003.00 
Adj. dividends per shareRs1.000.001.001.003.00 
Dividend yield (eoy) %0.100.20.20.4 
Book value per share (Unadj.) Rs174.1179.0194.6213.0247.1 
Adj. book value per shareRs174.1179.0194.6213.0247.4 
Shares outstanding (eoy) m126.20126.20126.20126.20126.35 
Bonus / Rights / Conversions  ----ESOS 
Price / Sales ratio x3.03.32.32.12.7 
Avg P/E ratio x37.099.537.228.923.3 
P/CF ratio (eoy) x21.736.919.716.616.5 
Price / Book Value ratio x4.34.22.92.63.3 
Dividend payout %5.006.55.38.6 
Avg Mkt Cap Rs m94,05795,72372,30069,120103,108 
No. of employees `00013.013.113.313.313.4 
Total wages/salary Rs m5,6516,2566,9607,3597,874 
Avg. sales/employee Rs Th2,416.42,213.32,414.62,477.42,807.0 
Avg. wages/employee Rs Th434.3476.4523.2555.2585.8 
Avg. net profit/employee Rs Th195.473.3146.2180.6329.0 
IPCA LABS INCOME DATA
Net Sales Rs m31,44429,06532,12232,83637,732 
Other income Rs m327222210418577 
Total revenues Rs m31,77129,28732,33233,25438,309 
Gross profit Rs m5,3632,8964,3814,5056,901 
Depreciation Rs m1,7961,6331,7301,7771,824 
Interest Rs m284319241240189 
Profit before tax Rs m3,6111,1662,6212,9055,465 
Minority Interest Rs m00000 
Prior Period Items Rs m-490000 
Extraordinary Inc (Exp) Rs m00000 
Tax Rs m1,0192046755111,042 
Profit after tax Rs m2,5429621,9452,3944,422 
Gross profit margin %17.110.013.613.718.3 
Effective tax rate %28.217.525.817.619.1 
Net profit margin %8.13.36.17.311.7 
IPCA LABS BALANCE SHEET DATA
Current assets Rs m19,34816,21917,41819,45523,778 
Current liabilities Rs m12,5179,7009,55910,07610,975 
Net working cap to sales %21.722.424.528.633.9 
Current ratio x1.51.71.81.92.2 
Inventory Days Days10710510098104 
Debtors Days Days7356576766 
Net fixed assets Rs m20,54021,42920,77920,43520,368 
Share capital Rs m252252252252253 
"Free" reserves Rs m21,56422,57824,30026,63330,971 
Net worth Rs m21,96522,59224,55326,88631,224 
Long term debt Rs m4,9874,8433,5172,3401,409 
Total assets Rs m41,24838,91739,59541,17345,507 
Interest coverage x13.74.711.913.130.0 
Debt to equity ratio x0.20.20.10.10 
Sales to assets ratio x0.80.70.80.80.8 
Return on assets %6.93.35.56.410.1 
Return on equity %11.64.37.98.914.2 
Return on capital %14.35.410.210.817.3 
Exports to sales %52.949.248.647.645.9 
Imports to sales %16.715.314.214.916.6 
Exports (fob) Rs m16,62414,29915,61715,64217,308 
Imports (cif) Rs m5,2474,4454,5714,8846,266 
Fx inflow Rs m16,74914,29915,61715,64217,308 
Fx outflow Rs m6,9565,8224,5714,8846,266 
Net fx Rs m9,7938,47711,04610,75911,042 
IPCA LABS CASH FLOW
From Operations Rs m 4,682 7,087 2,819 3,411 4,923 
From Investments Rs m -6,893 -2,183 -1,488 -1,354 -1,563 
From Financial Activity Rs m 2,505 -4,615 -1,591 -1,304 -1,832 
Net Cashflow Rs m 294 288 -260 753 1,528 
* Results Consolidated
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Share Holding

Indian Promoters 45.9%
Foreign collaborators 0.0%
Indian inst/Mut Fund 11.4%
FIIs 25.3%
ADR/GDR 0.0%
Free float 17.4%
Shareholders 36,892
Pledged promoter(s) holding 2.1%
 

Company Information

REGD OFF 48, Kandivli Industrial Estate, Kandivli (West), Mumbai - 400 067
E-MAIL investors@ipca.com WEB www.ipca.com
TELEPHONE (022) 6647 4444 FAX (022) 2868 6613
SECTOR PHARMACEUTICALS GROUP MISCELLANEOUS
TR AGENT Link Intime India, C13, Pannalal Silk Mills Cmpd., LBS Marg, Mumbai-78
AUDITOR Natvarlal Vepari & Co.
CHM: Premchand Godha (MD) COMP SEC: Harish P. Kamath (VP - Legal) YEAR OF INC: 1949 BSE CODE: 524494 FV (Rs): 2 DIV YIELD (%): 0.1

More Pharmaceuticals Company Fact Sheets:   CADILA HEALTHCARE  AMAR REMEDIES  TTK HEALTHCARE  ELDER PHARMA  ASTRAZENECA PHARMA  

Compare IPCA LABS With:   CADILA HEALTHCARE  AMAR REMEDIES  TTK HEALTHCARE  ELDER PHARMA  ASTRAZENECA PHARMA  

Compare IPCA LABS With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  




Today's Market

Indian Share Markets Open Higher; IndusInd Bank & SBI Top Gainers(09:30 am)

Asian stock markets are trading on a cautious note today ahead of what are expected to be upbeat readings on the Chinese economy.

Views on news

IPCA LABS Announces Quarterly Results (3QFY21); Net Profit Up 32.2% (Quarterly Result Update)

Feb 5, 2021 | Updated on Feb 5, 2021

For the quarter ended December 2020, IPCA LABS has posted a net profit of Rs 3 bn (up 32.2% YoY). Sales on the other hand came in at Rs 13 bn (up 15.5% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

IPCA LABS Announces Quarterly Results (1QFY21); Net Profit Up 243.5% (Quarterly Result Update)

Sep 29, 2020 | Updated on Sep 29, 2020

For the quarter ended June 2020, IPCA LABS has posted a net profit of Rs 5 bn (up 243.5% YoY). Sales on the other hand came in at Rs 15 bn (up 46.9% YoY). Read on for a complete analysis of IPCA LABS's quarterly results.

Dr Reddy's Lab Shares Fall As Earnings Miss Estimates. What Next? (Views On News)

May 14, 2021

The company's board recommended a final dividend of Rs 25 for financial year 2020-21.

What's Behind the Rally in Pharma Stocks? (Views On News)

May 11, 2021

The second wave of Covid has given a new lease of life to pharma stocks.

Why Did Alembic Pharma Shares Fall Today? (Views On News)

May 5, 2021

Covid-led supply disruptions of API fuel Alembic Pharma's global prospects.

More Views on News

Most Popular

Is Intraday Trading For You? (Fast Profits Daily)

May 13, 2021

Do you think you have what it takes to be an intraday trader? Find out in this video.

My Secret to Find Breakthrough Stocks (Fast Profits Daily)

May 7, 2021

I've used this trading technique for many years with great success. I'm sharing it with you today.

Are the Stock Markets Deaf to Covid Agony? (Profit Hunter)

May 6, 2021

Why are markets discounting the economic impact of Covid?

The Key to Profit from India's EV Revolution (Profit Hunter)

May 7, 2021

Stocks you must consider investing in before buying your first electric vehicle.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON IPCA LABS

IPCA LABS 8-QTR ANALYSIS

COMPARE IPCA LABS WITH

MARKET STATS